Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Rubnitz

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Leukemia|July 1, 1997
Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemiaK W Maloney, J E Rubnitz, M L Cleary, et al.
Blood|July 15, 1994
Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group studyJ E Rubnitz, M P Link, J J Shuster, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
p27KIP1 deletions in childhood acute lymphoblastic leukemiaH Komuro, M B Valentine, J E Rubnitz, et al.
Leukemia|June 1, 1996
High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in TaiwanD C Liang, T B Chou, J S Chen, et al.
Leukemia|April 13, 2011
Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot studyA K Mitra, K Crews, S Pounds, et al.
Blood|June 1, 1996
Molecular analysis of t(11;19) breakpoints in childhood acute leukemiasJ E Rubnitz, F G Behm, A M Curcio-Brint, et al.
Blood|December 24, 1998
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosisC Ito, M Kumagai, A Manabe, et al.
Leukemia|August 11, 1998
Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemiaJ E Rubnitz, M V Relling, P L Harrison, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Leukemia|April 14, 2000
Prognostic factors in infants with acute myeloid leukemiaC H Pui, S C Raimondi, D K Srivastava, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Leukemia|July 1, 1997
Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemiaK W Maloney, J E Rubnitz, M L Cleary, et al.
Blood|July 15, 1994
Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group studyJ E Rubnitz, M P Link, J J Shuster, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
p27KIP1 deletions in childhood acute lymphoblastic leukemiaH Komuro, M B Valentine, J E Rubnitz, et al.
Leukemia|June 1, 1996
High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in TaiwanD C Liang, T B Chou, J S Chen, et al.
Leukemia|April 13, 2011
Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot studyA K Mitra, K Crews, S Pounds, et al.
Blood|June 1, 1996
Molecular analysis of t(11;19) breakpoints in childhood acute leukemiasJ E Rubnitz, F G Behm, A M Curcio-Brint, et al.
Blood|December 24, 1998
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosisC Ito, M Kumagai, A Manabe, et al.
Leukemia|August 11, 1998
Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemiaJ E Rubnitz, M V Relling, P L Harrison, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Leukemia|April 14, 2000
Prognostic factors in infants with acute myeloid leukemiaC H Pui, S C Raimondi, D K Srivastava, et al.
Pageof 7